Introduction
============

Glycemic control is mandatory in the critically ill, because hypoglycemia and hyperglycemia are associated with increased mortality \[[@B1]\]. We compared in a prospective observational study three new point-of-care devices with the hexokinase reference method and we evaluated whether their results would modify insulin titration.

Methods
=======

Arterial blood glucose was simultaneously measured by the blood gas analyser RapidLab 1265, by three glucose meters (Accu-Chek performa, Precision XceedPro, Nova StatStrip), and with the hexokinase reference method. All values were duplicated and the average value of each was computed. Bland-Altman, Passing Bablok, Kanji \[[@B2]\] and modified Kanji approaches were performed. Biases were expressed as the glucose result of the point-of-care method minus the reference method. We evaluated the theoretical impact on insulin titration by comparing glucose meter results with the hexokinase reference method on a dynamic sliding scale targeting a glycemia of 80 to 130 mg/dl.

Results
=======

A total of 156 matched analyses were done in 80 patients. The mean flash SOFA score was 4.5. The range of the reference glucose was 25 to 327 mg/dl. The numbers of discrepancies of dosing insulin were respectively 8-5-6-14 at 0.1 U/hour, 0-6-3-6 at 0.2 U/hour and 2-3-0-0 at 0.3 U/hour. None was greater than 0.3 U/hour. Regarding the point-of-care results, total theoretical insulin dose changes were respectively: -11.7 U, -19.2 U, -22.2 U, +4.9 U for all these measurements (devices order as in Methods). Table [1](#T1){ref-type="table"} presents the standard comparisons.

                 Bias and 2SD   Passing reg           CI of slope
  -------------- -------------- --------------------- --------------
  RapidLab       -4.7 ± 14.6    *Y*= -4.8 + 1.1*X*    1.04 to 1.10
  AccuChek P     -9.5 ± 20.5    *Y*= 3.6 + 1.05*X*    1.00 to 1.11
  P Xceed Pro    -0.9 ± 15.4    *Y*= -4 + 1.03*X*     1.00 to 1.08
  Statstrip No   1.2 ± 18.1     *Y*= -0.4 + 0.98*X*   0.93 to 1.03

Conclusions
===========

Glucose monitoring with new glucose meters results has minor impact on intravenous insulin dose titration compared with the reference method.
